ArticleHuman vaccines & immunotherapeutics2024

Optimal implementation of an Ontario nirsevimab program for respiratory syncytial virus (RSV) prophylaxis: Recommendations from a provincial RSV expert panel.

Bosco Paes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.